Venkata Kanaka Naga Karthik Nasika
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Venkata Kanaka Naga Karthik Nasika has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Ashish Sharma
PGIMER
3 shared publications Jasmine Sethi
Department of Nephrology Postgraduate Institute of Medical Education and Research Chandigarh India
2 shared publicationsSarbpreet Singh
Department of Renal Transplant Surgery Postgraduate Institute of Medical Education and Research Chandigarh India
2 shared publicationsAbhinav Reddy
Departments of Renal Transplant Surgery
1 shared publicationDeepesh B Kenwar
Renal Transplant Surgery, Post Graduate Institute of Medical Education and Research, Chandigarh, India
1 shared publicationKajal Jain
Department of Anaesthesiology and Intensive Care Postgraduate Institute of Medical Education and Research Chandigarh India
1 shared publication
Latest Publications
- 6 February 2025
- Published by Wiley in Clinical Transplantation
- Vol. 39 (2) , e70090
Recipient Outcomes After Utilization of Kidneys From Deceased Donors With Diagnosed Glioblastoma Multiforme
Background: The exact incidence of donor tumor transmission in patients with glioblastoma multiforme (GBM) is still unknown. These transplants are usually considered as a high‐risk endeavor due to fear of potential spread especially with medical intervention leading to breach in blood–brain barrier. This report describes successful outcomes after renal transplantation from two donors with World Health Organization (WHO) Grade IV primary GBM who had undergone surgical excision with ventriculoperitoneal shunt (VPS).Methods: Between January 2019 and June 2024, case records of organ donors where the primary cause of death was GBM were screened from the departmental database. Renal transplant patients from donors with a histopathological diagnosis GBM WHO Grade IV were included in the study. The follow‐up of these recipients was recorded for tumor transmission, delayed graft function, patient and graft survival.Results: Only kidneys were retrieved from these donors. The donor's kidneys were transplanted to four consented recipients after taking informed consent explaining the risks. During the mean follow‐up of 3 years, all four patients were alive with good graft function. Nuclear scan at 3, 6 months, and yearly thereafter showed no abnormal uptake or no evidence of donor‐transmitted tumor transmission in any of these patients.Conclusion: High‐grade GBM donors with no evidence of systemic spread may be considered for renal transplantation.
- 6 February 2025
- Published by Wiley in Clinical Transplantation
- Vol. 39 (2) , e70090
Recipient Outcomes After Utilization of Kidneys From Deceased Donors With Diagnosed Glioblastoma Multiforme
Background: The exact incidence of donor tumor transmission in patients with glioblastoma multiforme (GBM) is still unknown. These transplants are usually considered as a high‐risk endeavor due to fear of potential spread especially with medical intervention leading to breach in blood–brain barrier. This report describes successful outcomes after renal transplantation from two donors with World Health Organization (WHO) Grade IV primary GBM who had undergone surgical excision with ventriculoperitoneal shunt (VPS).Methods: Between January 2019 and June 2024, case records of organ donors where the primary cause of death was GBM were screened from the departmental database. Renal transplant patients from donors with a histopathological diagnosis GBM WHO Grade IV were included in the study. The follow‐up of these recipients was recorded for tumor transmission, delayed graft function, patient and graft survival.Results: Only kidneys were retrieved from these donors. The donor's kidneys were transplanted to four consented recipients after taking informed consent explaining the risks. During the mean follow‐up of 3 years, all four patients were alive with good graft function. Nuclear scan at 3, 6 months, and yearly thereafter showed no abnormal uptake or no evidence of donor‐transmitted tumor transmission in any of these patients.Conclusion: High‐grade GBM donors with no evidence of systemic spread may be considered for renal transplantation.
- 14 January 2025
- Published by Wolters Kluwer Health in Pancreas
Simultaneous Pancreas and Kidney Transplantation From a Small Pediatric Donor with Ipsilateral Implantation Over Aortic Cuff
An abstract is unavailable. This article is available as a PDF only.
- 14 January 2025
- Published by Wolters Kluwer Health in Pancreas
Simultaneous Pancreas and Kidney Transplantation From a Small Pediatric Donor with Ipsilateral Implantation Over Aortic Cuff
An abstract is unavailable. This article is available as a PDF only.
- 4 January 2025
- Published by BMJ in BMJ Case Reports
- Vol. 18 (1) , e261484
Successful pregnancy outcome in a recipient of simultaneous pancreatic kidney transplantation
There is limited information available regarding post-simultaneous pancreatic kidney transplantation (SPKT) pregnancies. The present case describes a woman in her early 30s with first pregnancy who conceived spontaneously 4 years after SPKT. Her pancreatic and kidney graft function remained stable throughout the pregnancy. Creatinine was 0.6–0.7 mg/dL and Hemoglobin A1C (HbA1C) was 5.1%. There was no pre-eclampsia, gestational diabetes, rejection or infection. There was gestational thrombocytopenia, which was managed conservatively. Tacrolimus levels fell during the antenatal period and subsequently rose post partum. Mycophenolate was discontinued and switched to azathioprine 6 weeks prior. Caesarean section was done at 36 weeks because of oligohydramnios and vaginal warts delivering a healthy, live, full-term baby. Her graft function was stable on follow-up and the baby was doing well. High-risk pregnancies occur in female SPKT recipients. A multidisciplinary team should closely monitor the course of pregnancy events and immunosuppression.
- 4 January 2025
- Published by BMJ in BMJ Case Reports
- Vol. 18 (1) , e261484
Successful pregnancy outcome in a recipient of simultaneous pancreatic kidney transplantation
There is limited information available regarding post-simultaneous pancreatic kidney transplantation (SPKT) pregnancies. The present case describes a woman in her early 30s with first pregnancy who conceived spontaneously 4 years after SPKT. Her pancreatic and kidney graft function remained stable throughout the pregnancy. Creatinine was 0.6–0.7 mg/dL and Hemoglobin A1C (HbA1C) was 5.1%. There was no pre-eclampsia, gestational diabetes, rejection or infection. There was gestational thrombocytopenia, which was managed conservatively. Tacrolimus levels fell during the antenatal period and subsequently rose post partum. Mycophenolate was discontinued and switched to azathioprine 6 weeks prior. Caesarean section was done at 36 weeks because of oligohydramnios and vaginal warts delivering a healthy, live, full-term baby. Her graft function was stable on follow-up and the baby was doing well. High-risk pregnancies occur in female SPKT recipients. A multidisciplinary team should closely monitor the course of pregnancy events and immunosuppression.